248 related articles for article (PubMed ID: 26595741)
1. Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing?
Whelan FJ; Surette MG
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S207-11. PubMed ID: 26595741
[TBL] [Abstract][Full Text] [Related]
2. How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?
Rogers GB; Bruce KD; Hoffman LR
Curr Opin Pulm Med; 2017 Nov; 23(6):536-543. PubMed ID: 28786882
[TBL] [Abstract][Full Text] [Related]
3. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
4. The Lung Microbiome and Airway Disease.
Lynch SV
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2(Suppl 5):S462-S465. PubMed ID: 28005424
[TBL] [Abstract][Full Text] [Related]
5. [The lung microbiome in 2015: a window on chronic lung diseases].
Andréjak C; Delhaes L
Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
[TBL] [Abstract][Full Text] [Related]
6. Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information.
Cobián Güemes AG; Lim YW; Quinn RA; Conrad DJ; Benler S; Maughan H; Edwards R; Brettin T; Cantú VA; Cuevas D; Hamidi R; Dorrestein P; Rohwer F
mBio; 2019 Apr; 10(2):. PubMed ID: 30992350
[TBL] [Abstract][Full Text] [Related]
7. Chair's Summary: Mechanisms of Exacerbation of Lung Diseases.
Nicod LP; Kolls JK
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S112-4. PubMed ID: 26595726
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
Caverly LJ; LiPuma JJ
Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
[TBL] [Abstract][Full Text] [Related]
9. Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis.
Acosta N; Heirali A; Somayaji R; Surette MG; Workentine ML; Sibley CD; Rabin HR; Parkins MD
Thorax; 2018 Nov; 73(11):1016-1025. PubMed ID: 30135091
[TBL] [Abstract][Full Text] [Related]
10. The Microbiome in Cystic Fibrosis.
Huang YJ; LiPuma JJ
Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
[TBL] [Abstract][Full Text] [Related]
11. Development of the respiratory tract microbiota in cystic fibrosis.
de Koff EM; de Winter – de Groot KM; Bogaert D
Curr Opin Pulm Med; 2016 Nov; 22(6):623-8. PubMed ID: 27583669
[TBL] [Abstract][Full Text] [Related]
12. Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis.
Dmitrijeva M; Kahlert CR; Feigelman R; Kleiner RL; Nolte O; Albrich WC; Baty F; von Mering C
mBio; 2021 Mar; 12(2):. PubMed ID: 33688005
[TBL] [Abstract][Full Text] [Related]
13. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics.
Smith DJ; Badrick AC; Zakrzewski M; Krause L; Bell SC; Anderson GJ; Reid DW
Eur Respir J; 2014 Oct; 44(4):922-30. PubMed ID: 25034564
[TBL] [Abstract][Full Text] [Related]
14. What to expect when you're expectorating: cystic fibrosis exacerbations and microbiota.
Hoffman L; Surette M
Ann Am Thorac Soc; 2013 Jun; 10(3):249-50. PubMed ID: 23802823
[No Abstract] [Full Text] [Related]
15. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis.
Widder S; Carmody LA; Opron K; Kalikin LM; Caverly LJ; LiPuma JJ
Nat Commun; 2024 Jun; 15(1):4889. PubMed ID: 38849369
[TBL] [Abstract][Full Text] [Related]
16. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
[TBL] [Abstract][Full Text] [Related]
17. Chronic but not intermittent infection with
Boutin S; Graeber SY; Stahl M; Dittrich AS; Mall MA; Dalpke AH
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 28982777
[No Abstract] [Full Text] [Related]
18. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
Walicka-Serzysko K; Sands D
Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
[TBL] [Abstract][Full Text] [Related]
19. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.
Huang YJ; Lynch SV
Expert Rev Respir Med; 2011 Dec; 5(6):809-21. PubMed ID: 22082166
[TBL] [Abstract][Full Text] [Related]
20. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
